Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells

Oncogene

Volumn 34, Issue 18, 2015, Pages 2317-2324

  Koo, B S ^a   Lee, S H ^b   Kim, J M ^c   Huang, S ^c   Kim, S H ^a   Rho, Y S ^d   Bae, W J ^e   Kang, H J ^f   Kim, Y S ^f   Moon, J H ^f   Lim, Y C ^f  

^a Chungnam National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABCC6 PROTEIN, HUMAN; CYCLIN E; MULTIDRUG RESISTANCE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL; CANCER STEM CELL; CANCER TRANSPLANTATION; DRUG RESISTANCE; FEMALE; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN E; DRUG RESISTANCE, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84936120630     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.174     Document Type: Article

References (27)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
2. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001; 345: 1890-1900.
3. Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H et al. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. Int J Cancer 2010; 126: 437-449.
4. Lim YC, Oh SY, Cha YY, Kim SH, Jin X, Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol 2011; 47: 83-91.
5. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982-992.
6. Wang XQ, Ongkeko WM, Chen L, Yang ZF, Chen KK, Lopez JP et al. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 2010; 52: 528-539.
7. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 2008; 68: 6281-6291.
8. Scholer H, Ruppert S. New type of POU domain in germ line-specific protein Oct4. Nature 1990; 344: 435-439.
9. Nichols J, Zevnik B. Formation of pluripotent stem cells in the mammalian embryo depends. Cell 1998; 95: 379-391.
10. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma). Clin Cancer Res 2008; 14: 4085-4095.
11. Ge N, Lin HX, Xiao XS, Guo L, Xu HM, Wang X et al. Prognotic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. J Transl Med 2010; 8: 94.
12. Tsai LL, Yu CC, Chang YC, Yu CH, Chou MY. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med 2011; 40: 621-628.
13. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355: 1253-1261.
14. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008; 88: 808-815.
15. Wiegand S, Dunne AA, Muller HH, Mandic R, Barth P, Davis RK et al. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer 2005; 104: 94-100.
16. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
17. Yu F, Sim AC, Li C, Li Y, Zhao X, Wang DY, Loh KS. Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stem-like cell properties by high aldehyde dehydrogenase activity. Laryngoscope 2013; 123: 1903-1911.
18. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163.
19. Lengner CJ, Welstead GG, Jaenisch R. The pluripotency regulator Oct4: A role in somatic stem cells? Cell Cycle 2008; 7: 725-728.
20. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63: 2244-2250.
21. Jung JW, Park SB, Lee SJ. Metformin represses self-renewal of the human breast carcinoma stem cells. PLoS One 2011; 6: e28068.
22. Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, Alvarez RD et al. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 2012; 18: 869-881.
23. Chen KG, Sikic BI. Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 2012; 18: 1863-1869.
24. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
25. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 2012; 31: 4898-4911.
26. Gerrard L, Zhao D, Clark AJ, Cui W. Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 2005; 23: 124-133.
27. Xie LQ, Bian LJ, Li Z, Li Y, Li ZX, Li B. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma. Ann Surg Oncol 2010; 17: 1927-1936.